1,150
Participants
Start Date
March 9, 2016
Primary Completion Date
October 14, 2018
Study Completion Date
July 31, 2024
Enzalutamide
Oral
Placebo
Oral
Site TW88601, Kaohsiung City
Site TW88607, Taoyuan District
Site AU61016, Camperdown
Site AU61007, St Leonards
Site AU61013, Waratah
Site AU61009, Tweed Heads
Site AR54007, San Miguel de Tucumán
Site AU61001, Woodville South
Site IT39009, Candiolo
Site US10025, Newburgh
Site US10029, Syracuse
Site FR33014, Caen
Site US10011, Lancaster
Site DE49014, Hamburg
Site US10017, Towson
Site US10040, Virginia Beach
Site US10014, Durham
Site US10060, Greenville
Site US10009, Concord
Site US10068, Charlotte
Site US10012, Myrtle Beach
Site US10054, Thomasville
Site US10048, St. Petersburg
Site US10016, Homewood
Site US10059, Nashville
Site IT39011, Trento
Site TW88606, Taichung
Site US10044, Middleburg Heights
Site US10045, Jeffersonville
Site US10020, West Des Moines
Site DE49005, Bonn
Site US10015, Chicago
Site US10043, Springfield
Site US10036, Omaha
Site DE49013, Heidelberg
Site US10046, Dallas
Site US10035, Aurora
Site US10050, Denver
Site US10008, Tucson
Site US10056, La Jolla
Site US10034, Fountain Valley
Site FR33003, Créteil
Site US10026, Santa Rosa
Site US10013, Seattle
Site US10002, Burien
Site US10028, Wenatchee
Site US10007, Anchorage
Site US10055, Kansas City
Site US10018, Lawrenceville
Site US10004, Dallas
Site AR54002, Rosario
Site AR54010, Buenos Aires
Site AU61006, Sydney
Site AU61004, Ballarat
Site AU61015, Clayton
Site AU61017, Parkville
Site AU61008, St Albans
Site BE32001, Mons
Site BE32012, Ghent
Site BE32005, Kortrijk
Site BE32008, Liège
Site BE32007, Yvoir
Site CL56002, Temuco
Site CL56005, Viña del Mar
Site CL56001, Santiago
Site CL56007, Providencia
Site CL56004, Reñaca
Site CL56003, Santiago
Site DK45005, Aarhus
Site DK45008, Holstebro
Site DK45002, Copenhagen
Site DK45004, Aalborg
Site DK45003, Herlev
Site DK45001, Odense C
Site FI35802, Helsinki
Site FI35804, Pori
Site FI35803, Seinäjoki
Site FI35801, Tampere
Site FI35806, Jakobstad
Site FI35805, Oulu
Site FI35807, Turku
Site FR33010, Angers
Site FR33006, Bordeaux
Site FR33005, La Roche-sur-Yon
Site FR33015, Le Mans
Site FR33012, Lille
Site FR33007, Lyon
Site FR33011, Nîmes
Site FR33001, Pierre-Bénite
Site FR33009, Quimper
Site FR33013, Saint-Mandé
Site DE49002, Freiburg im Breisgau
Site DE49004, Nürtingen
Site IL97201, Kfar Saba
Site IL97211, Ẕerifin
Site IL97210, Beersheba
Site IL97202, Haifa
Site IL97205, Haifa
Site IL97206, Jerusalem
Site IT39005, Meldola
Site IT39004, Cremona
Site IT39003, Milan
Site IT39012, Milan
Site IT39007, Novara
Site IT39008, Pisa
Site IT39006, Padua
Site JP81003, Sakura
Site JP81001, Maebashi
Site JP81013, Kita-gun
Site JP81007, Yokohama
Site JP81016, Sendai
Site JP81010, Abeno-ku
Site JP81011, Chuo-ku
Site JP81012, Sayama
Site JP81006, Bunkyo-ku
Site JP81004, Koto-ku
Site JP81005, Shinjuku-ku
Site JP81017, Ube
Site JP81002, Chiba
Site JP81014, Fukuoka
Site JP81015, Fukuoka
Site JP81008, Kyoto
Site JP81018, Nagasaki
Site JP81020, Niigata
Site JP81019, Yamagata
Site NL31003, Nijmegen
Site NL31007, Nijmegen
Site NL31005, Eindhoven
Site NL31010, Alkmaar
Site NL31008, Amsterdam
Site NL31009, Zwolle
Site NL31002, Sneek
Site NL31006, Rotterdam
Site NZ64003, Tauranga
Site NZ64008, Kensington
Site NZ64002, Dunedin
Site NZ64005, Nelson
Site NZ64004, Hamilton
Site PL48007, Krakow
Site PL48003, Wroclaw
Site PL48011, Warsaw
Site PL48005, Gdansk
Site PL48010, Słupsk
Site PL48001, Mysłowice
Site RO40008, Cluj-Napoca
Site RO40009, Cluj-Napoca
Site RO40002, Floreşti
Site RO40011, Timișoara
Site RO40007, Brasov
Site RO40003, Bucharest
Site RO40006, Bucharest
Site RU70013, Ivanovo
Site RU70001, Moscow
Site RU70003, Moscow
Site RU70014, Moscow
Site RU70006, Omsk
Site RU70005, Penza
Site RU70007, Saint Petersburg
Site RU70008, Saint Petersburg
Site RU70009, Saint Petersburg
Site RU70012, Saint Petersburg
Site RU70016, Saint Petersburg
Site SK42110, Bratislava
Site SK42109, Košice
Site SK42102, Michalovce
Site SK42103, Nitra
Site SK42101, Poprad
Site SK42107, Trenčín
Site KR82008, Seongnam-si
Site KR82007, Busan
Site KR82004, Incheon
Site KR82001, Seoul
Site KR82002, Seoul
Site KR82003, Seoul
Site ES34011, Salamanca
Site ES34010, Sabadell
Site ES34012, Barcelona
Site ES34014, Barcelona
Site ES34006, Pamplona
Site ES34020, Oviedo
Site ES34013, Valencia
Site ES34001, Ávila
Site ES34007, Barcelona
Site ES34004, Madrid
Site ES34019, Madrid
Site SE46002, Örebro
Site SE46001, Malmo
Site SE46006, Stockholm
Site SE46004, Sundsvall
Site SE46007, Gothenburg
Site TW88605, Taipei
Site GB44002, Withington
Site CA15016, Edmonton
Site CA15024, Abbotsford
Site CA15003, Kelowna
Site CA15022, Kelowna
Site CA15010, Brampton
Site CA15021, Kingston
Site CA15013, Oakville
Site CA15020, Toronto
Site CA15023, Granby
Site CA15004, Montreal
Site SK42106, Žilina
Medivation LLC, a wholly owned subsidiary of Pfizer Inc.
INDUSTRY
Astellas Pharma Global Development, Inc.
INDUSTRY